Health-related quality of life and parental knowledge in patients with mucopolysaccharidosis receiving enzyme replacement therapy: A single-center cross-sectional study
Year: 2026
Type: article
Abstract: Background Mucopolysaccharidoses (MPS) are rare lysosomal storage disorders associated with progressive multisystem morbidity. This study evaluated clinical and sociodemographic characteristics, health-related quality of life (HRQoL), and parental disease knowledge in patients with MPS receiving enzyme replacement therapy (ERT). Methods This single-center cross-sectional study included 30 patients aged 2 years or older who had received ERT for at least 1 year, together with their primary caregivers. Parental knowledge was assessed using a 10-item questionnaire. HRQoL was evaluated using the Pediatric Quality of Life Inventory 4.0 (PedsQL) child self-report and parent-proxy forms, and participants aged 18 years or older completed the Short Form-36 (SF-36). Appropriate statistical tests were used for group comparisons and correlation analyses. Results The median age at diagnosis was 2.25 years, with a median 1-year delay from symptom onset to diagnosis. Most patients had MPS type IV or VI. PedsQL scores reported by both children and parents were significantly lower than population norms across multiple domains. Adult SF-36 domain scores did not differ significantly from population norms. The median parental knowledge score was 5/10, and misconceptions about disease mechanisms and treatment were common. Higher knowledge scores were found only in families with higher income. HRQoL was not associated with ERT duration, missed infusions, or parental knowledge scores. Conclusion Pediatric participants with MPS receiving ERT had impaired HRQoL compared with population norms, while parental disease-specific knowledge was limited in the overall study sample. Structured parental education and more flexible ERT delivery models may help reduce disruption to school and family life.
Authors: Ünzile Bayar Tapan, Serap Sivri
Institution: Hacettepe University
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,400
OpenAlex ID: W7237344730
